Cadherin-11 Regulates Motility in Normal Cortical Neural Precursors and Glioblastoma

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Schulte, Jessica D ^a   Srikanth, Maya ^a   Das, Sunit ^a,d   Zhang, Jianing ^a   Lathia, Justin D ^b   Yin, Lihui ^a   Rich, Jeremy N ^b   Olson, Eric C ^c   Kessler, John A ^a   Chenn, Anjen ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CADHERIN 11; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL MOTILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; MOLECULAR PATHOLOGY; MOUSE; NEURAL STEM CELL; NEUROEPITHELIUM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION;

ANIMALS; BLOTTING, WESTERN; CADHERINS; CELL MOVEMENT; CEREBRAL CORTEX; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GREEN FLUORESCENT PROTEINS; HUMANS; MALE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASTIC STEM CELLS; NEURAL STEM CELLS; PREGNANCY; RNA INTERFERENCE; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED;

EID: 84881343876     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070962     Document Type: Article

References (43)

1. Nieto MA, (2011) The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 27: 347-376.
2. Mani SA, Guo W, Liao M-J, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133: 704-715.
3. Thiery JP, (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
4. Roussos ET, Keckesova Z, Haley JD, Epstein DM, Weinberg RA, et al. (2010) AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment. Cancer Res 70: 7360-7364.
5. Lefranc F, Brotchi J, Kiss R, (2005) Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. J Clin Oncol 23: 11.
6. Hinds JW, Ruffett TL, (1971) Cell proliferation in the neural tube: an electron microscopic and golgi analysis in the mouse cerebral vesicle. Z Zellforsch Mikrosk Anat 115: 226-264.
7. Shoukimas GM, Hinds JW, (1978) The development of the cerebral cortex in the embryonic mouse: an electron microscopic serial section analysis. J Comp Neurol 179: 795-830.
8. Chenn A, Zhang YA, Chang BT, McConnell SK, (1998) Intrinsic polarity of mammalian neuroepithelial cells. Mol Cell Neurosci 11: 183-193.
9. Stocker AM, Chenn A (2006) Differential expression of alpha-E-catenin and alpha-N-catenin in the developing cerebral cortex. Brain Res.
10. Englund C, Fink A, Lau C, Pham D, Daza RA, et al. (2005) Pax6, Tbr2, and Tbr1 are expressed sequentially by radial glia, intermediate progenitor cells, and postmitotic neurons in developing neocortex. J Neurosci 25: 247-251.
11. Cameron DA, Middleton FA, Chenn A, Olson EC, (2012) Hierarchical clustering of gene expression patterns in the Eomes+lineage of excitatory neurons during early neocortical development. BMC Neurosci 13: 90.
12. Pollard SM, Yoshikawa K, Clarke ID, Danovi D, Stricker S, et al. (2009) Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4: 568-580.
13. Zhang J, Woodhead GJ, Swaminathan SK, Noles SR, McQuinn ER, et al. (2010) Cortical neural precursors inhibit their own differentiation via N-cadherin maintenance of beta-catenin signaling. Dev Cell 18: 472-479.
14. Chenn A, Walsh CA, (2002) Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science (New York, NY) 297: 365-369.
15. Woodhead GJ, Mutch CA, Olson EC, Chenn A, (2006) Cell-Autonomous beta-Catenin Signaling Regulates Cortical Precursor Proliferation. J Neurosci 26: 12620-12630.
16. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR, (2008) Cadherin switching. J Cell Sci 121: 727-735.
17. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
18. Pollard S, Clarke ID, Smith A, Dirks P, (2009) Brain Cancer Stem Cells: A Level Playing Field. Cell Stem Cell 5: 468-469.
19. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9: 157-173.
20. Leon SP, Folkerth RD, Black PM, (1996) Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77: 362-372.
21. Gilbertson RJ, Rich JN, (2007) Making a tumour's bed: glioblastoma stem cells and the vascular niche. Nature reviews 7: 733-736.
22. Carmeliet P, (2003) Angiogenesis in health and disease. Nat Med 9: 653-660.
23. Bruna A, Darken RS, Rojo F, Ocana A, Penuelas S, et al. (2007) High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene. Cancer Cell 11: 147-160.
24. Rich JN, (2003) The role of transforming growth factor-beta in primary brain tumors. Front Biosci 8: e245-260.
25. Merzak A, Koocheckpour S, Pilkington GJ, (1994) CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 54: 3988-3992.
26. Yoshida T, Matsuda Y, Naito Z, Ishiwata T, (2012) CD44 in human glioma correlates with histopathological grade and cell migration. Pathol Int 62: 463-470.
27. Maeda M, Johnson KR, Wheelock MJ, (2005) Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition. J Cell Sci 118: 873-887.
28. Barami K, Kirschenbaum B, Lemmon V, Goldman SA, (1994) N-cadherin and Ng-CAM/8D9 are involved serially in the migration of newly generated neurons into the adult songbird brain. Neuron 13: 567-582.
29. Nakagawa S, Takeichi M, (1995) Neural crest cell-cell adhesion controlled by sequential and subpopulation-specific expression of novel cadherins. Development 121: 1321-1332.
30. Nakagawa S, Takeichi M, (1998) Neural crest emigration from the neural tube depends on regulated cadherin expression. Development 125: 2963-2971.
31. Akitaya T, Bronner-Fraser M, (1992) Expression of cell adhesion molecules during initiation and cessation of neural crest cell migration. Dev Dyn 194: 12-20.
32. Stocker AM, Chenn A, (2009) Focal reduction of [alpha]E-catenin causes premature differentiation and reduction of [beta]-catenin signaling during cortical development. Developmental Biology 328: 66-77.
33. Kwon YT, Gupta A, Zhou Y, Nikolic M, Tsai LH, (2000) Regulation of N-cadherin-mediated adhesion by the p35-Cdk5 kinase. Curr Biol 10: 363-372.
34. Cheng WY, Kandel JJ, Yamashiro DJ, Canoll P, Anastassiou D, (2012) A multi-cancer mesenchymal transition gene expression signature is associated with prolonged time to recurrence in glioblastoma. PLoS One 7: e34705.
35. Mikheeva SA, Mikheev AM, Petit A, Beyer R, Oxford RG, et al. (2010) TWIST1 promotes invasion through mesenchymal change in human glioblastoma. Mol Cancer 9: 194.
36. Ikushima H, Todo T, Ino Y, Takahashi M, Miyazawa K, et al. (2009) Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors. Cell Stem Cell 5: 504-514.
37. Sullivan DP, Seidman MA, Muller WA, (2013) Poliovirus Receptor (CD155) Regulates a Step in Transendothelial Migration between PECAM and CD99. The American Journal of Pathology 182: 1031-1042.
38. Nutt CL, Mani DR, Betensky RA, Tamayo P, Cairncross JG, et al. (2003) Gene expression-based classification of malignant gliomas correlates better with survival than histological classification. Cancer Res 63: 1602-1607.
39. Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, et al. (2005) Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A 102: 5814-5819.
40. Lee J, Kotliarova S, Kotliarov Y, Li A, Su Q, et al. (2006) Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9: 391-403.
41. Bredel M, Bredel C, Juric D, Harsh GR, Vogel H, et al. (2005) High-resolution genome-wide mapping of genetic alterations in human glial brain tumors. Cancer Res 65: 4088-4096.
42. Sun L, Hui AM, Su Q, Vortmeyer A, Kotliarov Y, et al. (2006) Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain. Cancer Cell 9: 287-300.
43. Shai R, Shi T, Kremen TJ, Horvath S, Liau LM, et al. (2003) Gene expression profiling identifies molecular subtypes of gliomas. Oncogene 22: 4918-4923.